Semax: Researching the ACTH-Derived Peptide for Neurotrophic Support

04/09/2026 | Bio Bulk Peptides |

Semax is a synthetic heptapeptide analogue of the adrenocorticotropic hormone (ACTH) fragment 4–10. Specifically composed of the amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro, the compound has been extensively investigated for its potential neuroprotective and neurotrophic properties. Unlike the endogenous ACTH from which it is derived, this peptide has been engineered for metabolic stability and lacks systemic hormonal activity, making it a subject of interest in neurobiology and regenerative medicine research.

Molecular Specifications

  • Molecular Formula: C₃₉H₅₄N₁₀O₁₀S
  • Molecular Weight: 850.98 g/mol
  • Sequence: Met-Glu-His-Phe-Pro-Gly-Pro
  • Structure: Synthetic heptapeptide (ACTH 4–10 fragment)
  • Solubility: High water solubility
  • Purity: Research-grade specifications typically exceed 98%

Structural Derivation and Metabolic Stability

The development of Semax involved the modification of the core ACTH 4–10 sequence. In its native form, ACTH (adrenocorticotropic hormone) is a primary component of the hypothalamic-pituitary-adrenal (HPA) axis, responsible for stimulating the production of cortisol. However, research into the sub-fragments of ACTH revealed that the 4–10 region possessed neurotropic activity independent of adrenal stimulation.

To overcome the rapid enzymatic degradation that typically affects natural peptides, researchers stabilized the sequence by adding a Pro-Gly-Pro tripeptide to the C-terminus. This modification significantly enhances the peptide’s resistance to proteolysis (the breakdown of proteins into smaller polypeptides or amino acids) within the bloodstream and cerebrospinal fluid. Consequently, the compound maintains a longer half-life in research models compared to its parent fragment. Crucially, investigations have confirmed that Semax does not exhibit the hormonal effects associated with full-length ACTH, as it does not engage the adrenal cortex or influence steroidogenesis.

Minimalist representation of the Semax synthetic heptapeptide molecular structure for research.

Primary Mechanism: Upregulation of Neurotrophins

The most significant area of study regarding this heptapeptide involves its influence on Brain-Derived Neurotrophic Factor (BDNF). BDNF is a protein that serves as a vital growth factor for neurons, supporting the survival of existing neurons and encouraging the growth and differentiation of new neurons and synapses.

BDNF and NGF Expression

Research conducted in various laboratory settings has demonstrated that the administration of this compound leads to a rapid increase in the expression of BDNF mRNA and protein. In murine glial cell cultures, BDNF mRNA levels were observed to increase significantly shortly after exposure. Parallel studies involving the rat hippocampus showed that a single application resulted in:

  • A 1.4-fold increase in BDNF protein levels.
  • A 1.6-fold increase in TrkB (Tropomyosin receptor kinase B) tyrosine phosphorylation.
  • A notable increase in Nerve Growth Factor (NGF) mRNA levels.

Regional Specificity

The upregulation of neurotrophic factors appears localized to critical regions of the brain associated with executive function and memory consolidation. These include:

  • The Hippocampus: Essential for long-term memory and spatial navigation.
  • The Frontal Cortex: Responsible for higher-level cognitive processes and decision-making.
  • The Basal Forebrain: A major source of cholinergic innervation to the cortex.

By modulating these pathways, the compound may influence neuroplasticity, the brain’s ability to reorganize itself by forming new neural connections.

Research Applications in Neuroprotection

Investigating the neuroprotective capabilities of Semax is a priority for researchers studying ischemic stress and brain injury. Ischemia, a condition where blood flow (and thus oxygen) is restricted to a part of the body, often results in cellular death in the brain.

Ischemic Stress and Stroke Models

In preclinical models of ischemic stroke, the peptide has been studied for its ability to modulate the inflammatory response and reduce the zone of necrotic tissue. It is hypothesized that the compound influences the expression of genes involved in inflammation and the immune response following an injury. By downregulating certain pro-inflammatory cytokines and upregulating survival factors, the material may mitigate the "ischemic cascade" that follows a lack of oxygenated blood.

Cellular Resilience

Beyond physical injury, the compound is studied for its role in protecting neurons from excitotoxicity and oxidative stress. By enhancing neurotrophic signaling, the peptide may provide a buffer that allows neuronal networks to remain functional under metabolic stress. This makes it a potential reference point for studies involving age-related cognitive decline or environmental neurotoxicity.

Illustration of a protected neural network representing Semax research in neuroprotection and synaptic health.

Cognitive Enhancement and Synaptic Optimization

Research into the cognitive implications of this ACTH-derived fragment centers on its role in synaptic remodeling. Synapses are the junctions between neurons where information is transmitted; the density and health of these junctions are direct indicators of cognitive capacity in research models.

Key areas of cognitive research include:

  • Learning and Memory: Rodent studies utilizing water mazes and avoidance tasks have suggested that the peptide may facilitate faster acquisition of new tasks and better retention of learned behaviors.
  • Neurite Outgrowth: In vitro studies have observed enhanced branching and growth of neurites (projections from the cell body of a neuron), which are fundamental for establishing complex neural networks.
  • Cholinergic Modulation: There is evidence suggesting the compound may influence the cholinergic system, which is vital for focus, attention, and memory.

While often compared to its related compound, Selank, which is primarily studied for its anxiolytic (anxiety-reducing) properties, Semax remains the primary focus for researchers interested in pure cognitive stimulation and neurotrophic support.

Pharmacokinetics and Delivery in Research

The pharmacokinetic profile of this peptide is characterized by high bioavailability when administered via intranasal pathways. Because the peptide is small and highly water-soluble, it can bypass the blood-brain barrier relatively efficiently compared to larger proteins.

  • Absorption: Rapid penetration into the central nervous system (CNS).
  • Distribution: Detectable in various brain regions within minutes of administration in animal models.
  • Metabolism: Primary degradation occurs via peptidases, with the resulting amino acids being integrated into standard metabolic pathways.
  • Excretion: Eliminated through renal pathways.

For researchers exploring the efficacy of various delivery methods, the peptide offers a consistent model for observing rapid CNS changes without the complications of invasive administration. Related materials like Thymalin or Thymosin Alpha-1 are often studied in conjunction with neurotropic peptides to observe the interplay between the immune system and the brain.

Investigational Status and Safety in Preclinical Trials

Throughout various stages of preclinical research, Semax has demonstrated a notable safety profile. Because it is a fragment of a naturally occurring hormone already present in the human body, it is generally well-tolerated in laboratory environments. Research suggests a low incidence of toxicity even at high dosages in animal models.

However, it is critical to note that human clinical data in Western jurisdictions remains limited. Most existing human data originates from specific regional clinical uses that may not align with standard FDA or EMA protocols. Therefore, the compound is currently restricted to laboratory and research applications.

Storage and Handling Instructions

To maintain the structural integrity of the Semax-2 peptide, strict storage protocols must be followed:

  1. Lyophilized Powder: Store at -20°C for long-term stability (up to 24 months). If stored at 2-8°C (refrigeration), the powder remains stable for approximately 3-6 months.
  2. Reconstituted Solution: Once reconstituted with bacteriostatic water or sterile saline, the compound must be refrigerated at 2-8°C. It is recommended to use the solution within 7-14 days to prevent degradation.
  3. Light and Temperature: Avoid exposure to direct sunlight and high temperatures, as these will catalyze the breakdown of the peptide bonds.

DISCLAIMER: All products listed on biobulkpeptides.com, including Semax, are intended solely for LABORATORY RESEARCH PURPOSES. These compounds are not intended for human consumption, nor are they intended for diagnostic or therapeutic use in humans or animals.

FOR RESEARCH USE ONLY. This material must be handled by qualified professionals in a controlled laboratory environment. Any use of this product outside of documented research protocols is strictly prohibited. Research into this compound should be conducted with a thorough understanding of its biochemical properties and potential risks.

Orders are processed and shipped within 24-48 hours. Please refer to our About Us page for more information on our commitment to research-grade quality.

Not for human use. For research purposes only.